Amplitude Ventures, a full-stack venture capital firm focused on investing in precision medicine at the intersection of biology and AI, today announced the close of its $263 million (US$192 million) Fund II.
May 28, 2024
Amplitude Ventures, a full-stack venture capital firm focused on investing in precision medicine at the intersection of biology and AI, today announced the close of its $263 million (US$192 million) Fund II.
Venture Ontario
Suite 3001
250 Yonge St.
Toronto, ON M5B 2L7
